Blog
RSS FeedPosted by Michael Wonder on 01 Apr 2020
PHARMAC widens funding for lenalidomide for those with blood cancer
1 April 2020 - Emma Holden was devastated when she learned she had multiple myeloma. ...
Posted by Michael Wonder on 31 Mar 2020
COVID-19: cancer and rare disorder patients 'will die' if PHARMAC doesn't spend money on medicines
31 March 2020 - Those with cancer and rare medical conditions have asked the Prime Minister to relax PHARMAC's rules ...
Posted by Michael Wonder on 30 Mar 2020
PHARMAC eases restrictions on cancer drugs during COVID-19 pandemic
31 March 2020 - PHARMAC will ease restrictions on at least nine cancer drugs, including Keytruda, for the treatment of advanced ...
Posted by Michael Wonder on 11 Mar 2020
Bowel cancer patient heartbroken she needs unfunded drug Keytruda to survive
11 March 2020 - A 26-year-old with stage four bowel cancer is heartbroken that funding is the only thing standing ...
Posted by Michael Wonder on 11 Mar 2020
Decision to widen funded access to lenalidomide for multiple myeloma
11 March 2020 - PHARMAC is pleased to announce a decision to widen funded access to lenalidomide (Revlimid) to include ...
Posted by Michael Wonder on 05 Mar 2020
Life-extending breast cancer drug Ibrance to be fully funded from April
5 March 2020 - Wiki Mulholland, who has advanced breast cancer, and her husband Malcolm have long been campaigning to get ...
Posted by Michael Wonder on 04 Mar 2020
PHARMAC confirms new breast cancer medicine to be funded
4 March 2020 - New Zealanders with advanced breast cancer will be able to access palbociclib (marketed as Ibrance) from ...
Posted by Michael Wonder on 11 Feb 2020
Paying tax on unfunded cancer medication outrageous, says Nelson patient
7 February 2020 - A Nelson man with a rare cancer is concerned the Government is taking millions of dollars ...
Posted by Michael Wonder on 03 Feb 2020
Man's friends start NZ billboard campaign to raise funds for his cancer treatment
3 February 2020 - Friends of a cancer patient have rallied to rent billboards in Auckland to help fundraise for a ...
Posted by Michael Wonder on 14 Jan 2020
It's given me so much hope': PHARMAC announces breast cancer drug deal
15 January 2020 - Wiki Mulholland has watched friends die around her since her terminal breast cancer diagnosis 18 months ...
Posted by Michael Wonder on 14 Jan 2020
PHARMAC seeking views on new breast cancer medicine
15 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Pfizer to fund palbociclib (marketed as Ibrance) ...
Posted by Michael Wonder on 16 Dec 2019
Proposal to widen funded access to lenalidomide for multiple myeloma
16 December 2019 - PHARMAC is seeking feedback on a proposal to widened funded access to lenalidomide (Revlimid) to include ...
Posted by Michael Wonder on 05 Dec 2019
PHARMAC announces faster assessment of cancer medicines
4 December 2019 - From 1 January 2020, PHARMAC will assess funding applications for new cancer medicines at the same ...
Posted by Michael Wonder on 05 Dec 2019
Decision to widen access to bortezomib for multiple myeloma and AL amyloidosis
5 December 2019 - PHARMAC is pleased to announce a decision to widen access to bortezomib for patients with multiple ...
Posted by Michael Wonder on 05 Dec 2019
Decision to fund two new cancer treatments: olaparib and fulvestrant
5 December 2019 - PHARMAC is pleased to announce a decision to fund two new cancer treatments and amend the ...